The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 25, 2026 | Sullivan Mark | Chief Legal Officer | Sell(S) | 13K | $45.03 | $586K |
| Jun 25, 2026 | Roberts Brandi | Chief Financial Officer | Sell(S) | 3K | $45.03 | $136K |
| Jun 25, 2026 | Barrow Robert | Chief Executive Officer, Director | Sell(S) | 29K | $45.03 | $1.3M |
| Jun 25, 2026 | Karlin Daniel | Chief Medical Officer | Sell(S) | 10K | $45.03 | $452K |
| Jun 25, 2026 | Wiley Matthew T. | Chief Commercial Officer | Sell(S) | 3K | $45.03 | $129K |
| Jun 22, 2026 | Wiley Matthew T. | Chief Commercial Officer | Grant(A) | 63K | — | $0 |
| Jun 22, 2026 | Barrow Robert | Chief Executive Officer, Director | Grant(A) | 375K | — | $0 |
| Jun 22, 2026 | Roberts Brandi | Chief Financial Officer | Grant(A) | 63K | — | $0 |
| Jun 22, 2026 | Sullivan Mark | Chief Legal Officer | Grant(A) | 63K | — | $0 |
| Jun 22, 2026 | Karlin Daniel | Chief Medical Officer | Grant(A) | 100K | — | $0 |
| Jun 11, 2026 | Adsett Roger | Director | Grant(A) | 4K | — | $0 |
| Jun 11, 2026 | Adsett Roger | Director | Grant(A) | 15K | — | $0 |
| Jun 11, 2026 | Bruhn Suzanne Louise | Director | Grant(A) | 5K | — | $0 |
| Jun 11, 2026 | Bruhn Suzanne Louise | Director | Grant(A) | 19K | — | $0 |
| Jun 11, 2026 | Crystal Roger | Director | Grant(A) | 5K | — | $0 |
| Jun 11, 2026 | Crystal Roger | Director | Grant(A) | 19K | — | $0 |
| Jun 11, 2026 | Krebs Andreas | Director | Grant(A) | 5K | — | $0 |
| Jun 11, 2026 | Krebs Andreas | Director | Grant(A) | 19K | — | $0 |
| Jun 11, 2026 | Vallone Carol A | Director | Grant(A) | 5K | — | $0 |
| Jun 11, 2026 | Vallone Carol A | Director | Grant(A) | 19K | — | $0 |
| Jun 11, 2026 | Gryska David W | Director | Grant(A) | 5K | — | $0 |
| Jun 11, 2026 | Gryska David W | Director | Grant(A) | 19K | — | $0 |
| Mar 25, 2026 | Barrow Robert | Chief Executive Officer, Director | Sell(S) | 24K | $18.47 | $451K |
| Mar 25, 2026 | Sullivan Mark | Chief Legal Officer | Sell(S) | 11K | $18.47 | $198K |
| Mar 25, 2026 | Karlin Daniel | Chief Medical Officer | Sell(S) | 8K | $18.47 | $148K |
| Feb 3, 2026 | Barrow Robert | Chief Executive Officer, Director | Grant(A) | 320K | — | $0 |
| Feb 3, 2026 | Karlin Daniel | Chief Medical Officer | Grant(A) | 150K | — | $0 |
| Feb 3, 2026 | Sullivan Mark | Chief Legal Officer | Grant(A) | 125K | — | $0 |
| Feb 3, 2026 | Roberts Brandi | Chief Financial Officer | Grant(A) | 150K | — | $0 |
| Feb 3, 2026 | Wiley Matthew T. | Chief Commercial Officer | Grant(A) | 115K | — | $0 |
| Jan 29, 2026 | Adsett Roger | Director | Grant(A) | 50K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-13. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).